trending Market Intelligence /marketintelligence/en/news-insights/trending/R-AvmIVYqd0hSTEDlLwChg2 content esgSubNav
In This List

Aflac's adjusted earnings rise YOY in Q3, revenues tick down

Blog

Insurance Underwriting Transformed How Insurers Can Harness Probability of Default Models for Smarter Credit Decisions

Blog

The World's Largest P&C Insurers, 2023

Blog

The Worlds Largest Life Insurers, 2023

Blog

Essential IR Insights Newsletter Fall - 2023


Aflac's adjusted earnings rise YOY in Q3, revenues tick down

Aflac Inc. reported third-quarter adjusted earnings of $863 million, or $1.16 per share, versus $792 million, or $1.03 per share, a year ago.

Net earnings were $777 million, or $1.04 per share, compared with $845 million, or $1.09 per share, in the year-ago period.

Net earnings included pretax net realized investment losses of $119 million, or 16 cents per share, versus pretax net gains of $88 million, or 11 cents per share, a year earlier.

The S&P Global Market Intelligence consensus normalized EPS estimate for the quarter was $1.07 per share.

Total revenues decreased year over year to $5.54 billion from $5.58 billion in the third quarter of 2018.

Aflac Japan premium income increased 2.6% to $3.2 billion in the third quarter. Net investment income, net of amortized hedge costs, increased 8.7% to $659 million, while total revenues rose 3.6% to $3.9 billion.

The pretax adjusted profit margin for the Japan segment was 21.4%, versus 20.1% a year earlier. The average yen/dollar exchange rate in the third quarter was 107.31, or 3.9% stronger than the average rate of 111.48 a year earlier.

Aflac U.S. premium income increased 1.3% to $1.4 billion in the period. Net investment income decreased 2.1% to $183 million. Total revenues rose 0.9% to $1.6 billion. Pretax adjusted earnings were $335 million, up 0.3%, driven by an improvement in the benefit ratio partially offset by higher anticipated expenses in the quarter. The pretax adjusted profit margin for the U.S. segment was 20.6%, compared with 20.7% a year earlier.

Aflac U.S. sales decreased 4.2% to $344 million.